BIOMERICA (BMRA) Stock: Buy, Sell, or Hold?
$1.36
+0.00 (+0.00%)
▲
5d:
-12.26%
30d:
-26.49%
90d:
-15.0%
Open in Live Scanner
70/30 Portfolio Builder
Last Earnings: Oct 13, 2026
Updated Nov 13, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
45/100
Position
OVERSOLD
30-Day Fair Range
$1.53 – $1.84
Position: OVERSOLD
Wall Street Target
$13.00
+855.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.27 / $1.79
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: BMRA is down 12.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When BMRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BMRA is currently trading at $1.36, which is considered oversold relative to its 30-day fair value range of $1.53 to $1.84.
Technical Outlook: Technically, BMRA is showing sideways momentum. Immediate support is located at $1.27, while resistance sits at $1.79.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $13.00 (+855.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BMRA is showing sideways momentum. Immediate support is located at $1.27, while resistance sits at $1.79.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $13.00 (+855.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.53 -
$1.84
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$1.53 -
$1.84
Current vs Trading Range
OVERSOLD
Support Level
$1.27
Resistance Level
$1.79
Current Trend
Sideways
Technical data as of
Nov 16, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (58/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 855.9% below Wall St target ($13.00)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Wall Street Target
$13.00
(+855.9%)
Revenue Growth (YoY)
-8.3%
Profit Margin
-115.5%
Share BMRA Analysis
Share this live BMRA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BMRA)
Bullish
3 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Oct 23, 2026
Daily AI digest
AI Retail Discussion Summary:
Biomerica, Inc. ($BMRA) announced a contract-development agreement with initial target fees exceeding $1.75 million. The work is expected to utilize existing facilities and staff.
Key Retail Themes:
Business Development
Contracts
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 16, 2026 2:36 PM ET
Data refreshes hourly during market hours. Next update: 3:36 PM
Data refreshes hourly during market hours. Next update: 3:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BMRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$99 | 54 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 59 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 48 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$339 | 44 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$113 | 32 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BMRA Research Pages
BMRA Technical Chart
BMRA Price Prediction
BMRA Intrinsic Value DCF
BMRA Earnings Date
BMRA Investment Advisor
BMRA Fair Price Analyzer
BMRA Target Price Playground
BMRA LEAP Simulator
BMRA Supply Chain Tear-Down
Engineering R&D & Supply-Chain Velocity Hub
AI Chip Cost & Reticle Wall Visualizer
House Thesis Scoreboard & Risk Guard
BMRA Competitors
Part B: Tradestie Flagship Market Scanners